Abuse prevention controlled release opioid dosage form

• 收藏
• 分享

专利权人:

ムンディファーマ インターナショナル コーポレイション リミテッド

发明人:

フランク エス． カルソ,フアイ－フン カオ,フランク エス. カルソ,フアイ-フン カオ

申请号：

JP2014125979

公开号：

JP5977784B2

申请日:

2014.06.19

申请国别(地区):

JP

年份:

2016

代理人:

摘要：

Abuse-resistant, controlled release opioid tablets are a combination containing an opioid antagonist such as naloxone at a level that needed to suppress the euphoric effect of the opioid, if the combination were crushed to break the controlled release properties causing the opioid and opioid antagonist to be released as a immediate release product as a single dose. The controlled release nature of the table prevents the accumulation of orally effective amounts of opioid antagonist when taken normally. The opioid antagonist is contained in a controlled-release matrix and released, over time, with the opioid.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/